Floatz logo

Rapamycin

Myelofibrosis

Masonic Cancer Center, University of MinnesotaPhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
73/ 100

Competitive context

48 Active assets in the Myelofibrosis cohort.

Asset / SponsorPhaseRating
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2BB
CYCLOSPORIN A
City of Hope Medical Center
Phase 2B
Cyclophosphamide
City of Hope Medical Center
Phase 3B
Busulphan
City of Hope Medical Center
Phase 2B
Fludarabine
Center for International Blood and Marrow Transplant Research
Phase 3B

View all 50 →

Same molecule, other indications

Rapamycin is also rated in:

tuberous sclerosisDormant
BBB
Indicative ·
73 / 100
View asset →
disease related to transplantationDormant
BBB
Indicative ·
72 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →